Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1253/circj.CJ-22-0827 | DOI Listing |
Publication Analysis
Top Keywords
jcs/jhrs 2022
4
2022 guideline
4
guideline diagnosis
4
diagnosis risk
4
risk assessment
4
assessment arrhythmia
4
jcs/jhrs
1
guideline
1
diagnosis
1
risk
1
Similar Publications
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.
Circ J
August 2024
Department of Pediatric Cardiology, Saitama Medical University International Medical Center.
JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk - Reply.
Circ J
June 2022
Department of Cardiovascular Medicine, Nippon Medical School.
JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk.
Circ J
June 2022
Medical Affairs, Bayer Yakuhin, Ltd.